Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT00253669
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed newly diagnosed malignant brain tumor
* Supratentorial grade III or IV astrocytoma of 1 of the following types:
* Anaplastic astrocytoma
* Anaplastic oligodendroglioma
* Glioblastoma multiforme
* No prior thrombotic event
PATIENT CHARACTERISTICS:
Performance status
* Karnofsky 60-100%
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
* No prior immunotherapy or biologic agents, including immunotoxins, immunoconjugates, antisense therapy, peptide-receptor antagonists, interferons, interleukins, tumor-infiltrating lymphocytes, lymphocyte-activated killer cells, or gene therapy, for the brain tumor
Chemotherapy
* No prior chemotherapy for the brain tumor except polifeprosan 20 with carmustine implant (Gliadel wafer)
Endocrine therapy
* No prior hormonal therapy for the brain tumor except glucocorticoids
Radiotherapy
* No prior radiotherapy for the brain tumor
* No prior cranial irradiation
Other
* No concurrent chronic anticoagulation therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00253669
Study Brief:
Protocol Section:
NCT00253669